Noevir Holdings Co Ltd
TSE:4928
Noevir Holdings Co Ltd
Interest Income Expense
Noevir Holdings Co Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Noevir Holdings Co Ltd
TSE:4928
|
Interest Income Expense
¥121m
|
CAGR 3-Years
85%
|
CAGR 5-Years
62%
|
CAGR 10-Years
3%
|
|
Shiseido Co Ltd
TSE:4911
|
Interest Income Expense
¥7.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
35%
|
CAGR 10-Years
19%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Interest Income Expense
¥1.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Interest Income Expense
¥2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
Kao Corp
TSE:4452
|
Interest Income Expense
¥5.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
34%
|
CAGR 10-Years
9%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Interest Income Expense
¥1.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
24%
|
CAGR 10-Years
16%
|
See Also
What is Noevir Holdings Co Ltd's Interest Income Expense?
Interest Income Expense
121m
JPY
Based on the financial report for Dec 31, 2023, Noevir Holdings Co Ltd's Interest Income Expense amounts to 121m JPY.
What is Noevir Holdings Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
3%
Over the last year, the Interest Income Expense growth was 26%. The average annual Interest Income Expense growth rates for Noevir Holdings Co Ltd have been 85% over the past three years , 62% over the past five years , and 3% over the past ten years .